SF3B4 mRNA expression was higher in CC patients with copy number amplification than in nonamplified samples (Fig. 1I), and SF3B4 genomic amplification contributed to its high mRNA expression in cervical cancer tissues and cell lines (Fig. 1J). This evidence concerns the gene SF3B4 and cervical cancer.